Evidence map›Paper›PMID 40092864›Full record

ArticleBioinformation2024

The ctDNA revolution: Insights on cancer care: A narrative review.

Krutika Mahendra Gohil, Jyothika Venkataswamy Reddy, Saniya Kifayetulla Mulla, Rutu Snehal Shah, Shrunga Kandhi Raghavendra, Rishika Singh, Sagar Mahendra Gohil

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Krutika Mahendra GohilDepartment of Internal Medicine, Hinduhridaysamrat Balasaheb Thackarey Medical College (HBTMC) and Dr. Rustom Narsi Cooper Municipal General Hospital, Mumbai, Maharashtra, India.
Jyothika Venkataswamy ReddyDepartment of Medicine, Chamarajanagar Institute of Medical Sciences, Chamarajanagar, Karnataka, India.
Saniya Kifayetulla MullaDepartment of Internal Medicine, Hinduhridaysamrat Balasaheb Thackarey Medical College (HBTMC) and Dr. Rustom Narsi Cooper Municipal General Hospital, Mumbai, Maharashtra, India.
Rutu Snehal ShahDepartment of Medicine Dr. Vaishampayan Memorial Government Medical College, Solapur, Maharashtra, India.
Shrunga Kandhi RaghavendraDepartment of Medicine, Chamarajanagar Institute of Medical Sciences, Chamarajanagar, Karnataka, India.
Rishika SinghDepartment of Internal Medicine, Hinduhridaysamrat Balasaheb Thackarey Medical College (HBTMC) and Dr. Rustom Narsi Cooper Municipal General Hospital, Mumbai, Maharashtra, India.
Sagar Mahendra GohilDepartment of Medicine Mahatma Gandhi Mission Institute of Health Sciences, Navi Mumbai, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor DNA (ctDNA) is a revolutionary tool in the detection and monitoring of cancer: a minimally invasive, highly sensitive approach to analysing tumor-specific DNA in the bloodstream. Therefore, it is of interest to explore the current and evolving landscape of cancer genomics as precision tools in quantifying tumor dynamics. Thus, the role of ctDNA in tracking minimum residual disease, relapse, recurrence and the tailoring of therapeutic strategies for effective management of tumours is reviewed.

Indexed as

cancerctDNAgenomicspredictive markertumor specific DNA

Identifiers

PMID40092864
PMCPMC11904137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.